Major Depression: Clinical Trials

50 trials for Major Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 9 unknown, 8 terminated. 50 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 450Completed 33, Unknown 9, Terminated 8

Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression

Trials (filtered) newest first · largest first

All 50 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
Bupropion XL, Escitalopram - Major Depression
Phase 4CompletedEmory University182020-09-232023-12-29
Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine
Vortioxetine - Depressive Disorder, Major Depression
Phase 4TerminatedMassachusetts General Hospital22017-08-242019-10-14
The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Ketamine Hydrochloride - Major Depression, Bipolar I Disorder
Phase 4CompletedMayo Clinic752017-06-012022-03-15
Escitalopram Plus PS128 vs. Escitalopram
Lactobacillus plantarum PS128 - Major Depression
Phase 4TerminatedKaohsiung Kai-Suan Psychiatric Hospital412016-11-182019-09-18
Bupropion for Depression in ESRD Patients on Hemodialysis
Fluoxetine, Bupropion - Major Depression, End Stage Renal Disease
Phase 4TerminatedUniversity of Arkansas12016-03-312018-07-17
Measurement-based Care for Depression in Resource-Poor Settings
Fluoxetine, Enhanced Usual Care - Major Depression
Phase 4CompletedFlorida International University1402014-02-012016-12-01
Effectiveness of Repetitive Transcranial Magnetic Stimulation in Depressed Patients
Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation - Major Depression
Phase 4UnknownUniversidad Nacional Autonoma de Mexico802013-09-012014-08-11
Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression
venlafaxine, fluoxetine - Major Depression
Phase 4CompletedCapital Medical University1892013-03-072017-09-14
Effectiveness Study of Mirtazapine Combined With Paroxetine in Major Depressive Patients Without Early Improvement
mirtazapine, paroxetine 20mg QD - Major Depression
Phase 4CompletedCapital Medical University5252012-11-142017-08-31
Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy
Sevoflurane, Ketamine - Major Depression, Electroconvulsive Therapy
Phase 4CompletedInonu University242012-02-012013-06-06
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
Selective Serotonin Reuptake Inhibitor (SSRI) - Bipolar Disorder, Major Depression
Phase 4CompletedThe Cleveland Clinic1922011-11-012019-12-02
Effect of Antidepressants on White Matter Structure
Desvenlafaxine - Major Depression
Phase 4UnknownCentre de Recherche de l'Institut Universitaire en santé Mentale de Montréal402011-11-012011-12-15
Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene
Paroxetine, Sertraline, Citalopram - Major Depression
Phase 4UnknownHolsboerMaschmeyer NeuroChemie GmbH802011-09-012014-09-12
Inflammatory Markers and Cognitive Function in Major Depression
Duloxetine - Major Depression
Phase 4UnknownCentre de Recherche de l'Institut Universitaire en santé Mentale de Montréal202011-07-012012-07-19
Efficacy Study of Botox for Depression
Botox, Saline Solution - Major Depression
Phase 4UnknownCapital Clinical Research Associates, LLC602011-02-012012-03-19
Efficacy and Safety Curcumin in Depression
curcumin - Major Depression
Phase 4CompletedVladimir Lerner402010-08-012013-02-07
Interpersonal Therapy for Depression in Breast Cancer
Interpersonal Psychotherapy, Problem-Solving Therapy, Brief Supportive Psychotherapy - Major Depression
Phase 4CompletedNew York State Psychiatric Institute1342009-10-012017-07-18
Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)
escitalopram, nortriptyline - Major Depression
Phase 4TerminatedHillerod Hospital, Denmark472009-08-012014-12-09
Electroconvulsive Therapy (ECT) for Elderly Patients With Major Depression
ECT - Major Depression
Phase 4CompletedDiakonhjemmet Hospital922009-08-012015-07-09
Changes of Functional Connectivity After rTMS in Depression
repetitive transcranial magnetic stimulation(rTMS), Sham repetitive transcranial magnetic stimulation(rTMS) - Major Depression
Phase 4CompletedYonsei University442009-05-012012-02-02

Showing 20 of 50. Sign in to see all of them.

Narrower conditions

Depressive Disorder, Major (50)  ·  Depression (15)  ·  Anxiety Disorders (3)  ·  Bipolar Disorder (2)  ·  Depressive Disorder (2)  ·  Diabetes Mellitus (2)  ·  Dysthymic Disorder (2)  ·  Generalized Anxiety Disorder (2)  ·  Inflammation (2)  ·  Mood Disorders (2)  ·  Pain (2)  ·  Psychological Well-Being (2)  ·  Abdominal Pain (1)  ·  Alcoholism (1)  ·  Cognitive Dysfunction (1)

Broader conditions

Mental Disorders (50)  ·  Depressive Disorder (48)  ·  Mood Disorders (48)  ·  Behavior (15)  ·  Behavioral Symptoms (15)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Nervous System Diseases (4)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pathologic Processes (3)  ·  Signs and Symptoms (3)  ·  Bipolar and Related Disorders (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)

Interventions

Escitalopram (12)  ·  Bupropion (5)  ·  Duloxetine Hydrochloride (4)  ·  Fluoxetine (4)  ·  Sertraline (4)  ·  Ketamine (3)  ·  Paroxetine (3)  ·  Transcranial Magnetic Stimulation (3)  ·  Venlafaxine Hydrochloride (3)  ·  Interpersonal Psychotherapy (2)  ·  Nortriptyline (2)  ·  Quetiapine Fumarate (2)  ·  Triiodothyronine (2)  ·  Acamprosate (1)  ·  Amitriptyline (1)

Sponsors

New York State Psychiatric Institute (6)  ·  Emory University (3)  ·  Indiana University (3)  ·  Capital Medical University (2)  ·  Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal (2)  ·  University of California, Los Angeles (2)  ·  University of Pittsburgh (2)  ·  Weill Medical College of Cornell University (2)  ·  Baylor College of Medicine (1)  ·  Capital Clinical Research Associates, LLC (1)  ·  Conrad, Erich J., M.D. (1)  ·  Diakonhjemmet Hospital (1)  ·  Dr Alexander McIntyre Inc. (1)  ·  Florida International University (1)  ·  Hillerod Hospital, Denmark (1)

Countries

United States (27)  ·  Canada (4)  ·  China (2)  ·  Germany (2)  ·  Israel (2)  ·  Taiwan (2)  ·  Brazil (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Haiti (1)  ·  Italy (1)  ·  Mexico (1)  ·  Norway (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Amit Anand, MD (3)  ·  Jonathan W. Stewart, MD. (2)  ·  Alexander W McIntyre, FRCPC (1)  ·  Amit Anand, M.D. (1)  ·  Andrea Fagiolini, M.D. (1)  ·  Andrew F Leuchter, MDe (1)  ·  Andrew Miller, MD (1)  ·  Andrew Nierenberg, M.D. (1)  ·  Boadie W Dunlop, MD, MS (1)  ·  Casas Miguel, Prof. (1)  ·  Ching-Kuan Wu, M.D. (1)  ·  Claire Deng, M.D. (1)  ·  Dunja Hinze-Selch, MD (1)  ·  Eduard Maron, MD, PhD (1)

Results publications

PMID 16946178, PMID 19193344, PMID 19288975, PMID 19545857, PMID 19820552, PMID 20144692, PMID 20187924, PMID 21672502, PMID 22964160, PMID 24345483, PMID 24504819, PMID 24972362, PMID 25271445, PMID 25590761, PMID 26529118, PMID 27379563, PMID 29940870, PMID 30579045, PMID 34011310, PMID 34718252, PMID 34838606, PMID 38142892, PMID 38479192, PMID 42702010

NIH funding

M01RR000071 (1), R01MH056946 (1), R21DK097470 (1), R21MH121891 (1)